Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr;30(4):375-380.
doi: 10.1111/iju.15135. Epub 2022 Dec 27.

Efficacy and patient satisfaction of low-intensity shockwave treatment for erectile dysfunction in a retrospective real-world study in Japan

Makoto Kurosawa  1 , Akira Tsujimura  1 , Junki Morino  1 , Yuta Anno  1 , Azusa Yoshiyama  1 , Akimasa Kure  1 , Yuka Uesaka  1 , Taiji Nozaki  1 , Masato Shirai  1 , Kazuhiro Kobayashi  2 , Shigeo Horie  3
Affiliations

Efficacy and patient satisfaction of low-intensity shockwave treatment for erectile dysfunction in a retrospective real-world study in Japan

Makoto Kurosawa et al. Int J Urol. 2023 Apr.

Abstract

Objectives: To clarify the efficacy of low-intensity extracorporeal shockwave therapy for patients with erectile dysfunction, compare the efficacy between two types of lithotripters (ED1000 [focused type] and Renova [linear type]), and detect factors indicative of therapeutic gain with the treatment.

Methods: This retrospective study included 76 patients (52.8 ± 11.7 years) treated by ED1000 (12 times over 9 weeks) and 484 patients (52.5 ± 11.6 years) treated by Renova (4 times over 4 weeks). Age, sexual symptoms scores, and blood examinations were assessed. Efficacy was judged by improvement of the scores and patient satisfaction and compared between patients at 1 month after treatment with the lithotripters. Independent factors influencing efficacy by Renova were also assessed.

Results: Sexual symptom scores were improved significantly by both lithotripters, although the changes in the scores did not differ significantly between them. Efficacy rate as judged by patient satisfaction was 65.8% with the ED1000 and 71.1% with Renova, also without significant difference. Among several factors including age, sexual symptoms scores, endocrinological factors, metabolic factors, and the rate of phosphodiesterase type 5 inhibitor use, only age was found to be an independent factor influencing the efficacy of Renova.

Conclusion: We clearly showed the high efficacy of both lithotripters. Although the efficacy rate did not differ between them, we speculated that the fewer treatment sessions needed with the Renova versus the ED1000 would be a great advantage for patients. We also suggest that Renova should be recommended for patients younger than 70 years of age.

Keywords: Erection Hardness Score; Sexual Health Inventory for Men; erectile dysfunction; satisfaction; shockwave treatment.

PubMed Disclaimer

References

REFERENCES

    1. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84:50-6.
    1. Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200:633-41.
    1. Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. European Association of Urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction. Eur Urol. 2021;80:333-57.
    1. Japanese Society for Sexual Medicine, Japanese Urological Association. JSSM guidelines for erectile dysfunction. 3rd ed. Tokyo: RichHill Medical; 2018 (in Japanese).
    1. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA, et al. Oral sildenafil in the treatment of erectile dysfunction. 1998. J Urol. 2002;167:1197-203. discussion 1204.

LinkOut - more resources